Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
8.61
+0.25 (2.99%)
At close: Jun 2, 2026, 4:00 PM EDT
8.50
-0.11 (-1.28%)
Pre-market: Jun 3, 2026, 7:38 AM EDT
Decoy Therapeutics Market Cap
Decoy Therapeutics has a market cap or net worth of $4.58 million as of June 3, 2026. Its market cap has increased by 159.26% in one year.
Market Cap
4.58M
Enterprise Value
-3.24M
1-Year Change
159.26%
Ranking
Category
Stock Price
$8.61
Market Cap Chart
Since July 22, 2019, Decoy Therapeutics's market cap has decreased from $44.18M to $4.58M, a decrease of -89.63%. That is a compound annual growth rate of -28.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 4.58M | 10.58% |
| Dec 31, 2025 | 4.14M | 56.21% |
| Dec 31, 2024 | 2.65M | 3.58% |
| Dec 29, 2023 | 2.56M | -26.55% |
| Dec 30, 2022 | 3.49M | -84.43% |
| Dec 31, 2021 | 22.39M | 3.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silo Pharma | 5.41M |
| Dermata Therapeutics | 5.39M |
| TransCode Therapeutics | 5.16M |
| Pulmatrix | 5.08M |
| Galmed Pharmaceuticals | 4.79M |
| Alzamend Neuro | 4.45M |
| CDT Equity | 4.35M |
| Revelation Biosciences | 4.26M |